Guideline

Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020

Linda-Gail Bekker, Benjamin Brown, Dvora Joseph-Davey, Kathrine Gill, Michelle Moorhouse, Sinead Delany-Moretlwe, Landon Myer, Catherine Orrell, Kevin Rebe, W.D. Francois Venter, Carole L. Wallis
Southern African Journal of HIV Medicine | Vol 21, No 1 | a1152 | DOI: https://doi.org/10.4102/sajhivmed.v21i1.1152 | © 2020 Linda-Gail Bekker, Benjamin Brown, Dvora Joseph-Davey, Kathrine Gill, Michelle Moorhouse, Sinead Delany-Moretlwe, Landon Myer, Catherine Orrell, Kevin Rebe, W.D. Francois Venter, Carole L. Wallis | This work is licensed under CC Attribution 4.0
Submitted: 14 August 2020 | Published: 10 December 2020

About the author(s)

Linda-Gail Bekker, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Benjamin Brown, Anova Health Institute, Johannesburg, South Africa
Dvora Joseph-Davey, Department of Epidemiology, University of California, Los Angeles, United States of America; and, Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Kathrine Gill, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Michelle Moorhouse, Wits Reproductive Health and HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
Landon Myer, Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Catherine Orrell, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; and, Department of Medicine, University of Cape Town, Cape Town, South Africa
Kevin Rebe, Life Vincent Pallotti Hospital, Cape Town, South Africa; and, Department of Medicine and Infectious Diseases, University of Cape Town, Cape Town, South Africa
W.D. Francois Venter, Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Carole L. Wallis, BARC-SA, Speciality Molecular Division, Lancet Laboratories, Johannesburg, South Africa

Abstract

No abstract  available.

Keywords

pre-exposure prophylaxis; HIV; prevention tools; pregnant and breastfeeding women; transgender women

Metrics

Total abstract views: 5315
Total article views: 5272

 

Crossref Citations

1. Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap
Dvora L Joseph Davey, Linda-Gail Bekker, Elizabeth A Bukusi, Benjamin H Chi, Sinead Delany-Moretlwe, Ameena Goga, Anne Drapkin Lyerly, Nyaradzo M Mgodi, Nelly Mugo, Landon Myer, Lisa M Noguchi, Lynda Stranix-Chibanda, Catherine Slack, Jillian Pintye
The Lancet HIV  vol: 9  issue: 3  first page: e214  year: 2022  
doi: 10.1016/S2352-3018(21)00280-0